SCHEMBL10035967

SCHEMBL10035967

CCN1/C(=C/C(C)=C/c2sc3c4ccccc4ccc3[n+]2CC)Sc2c1ccc1ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 7/20 1.00
NSD2 O96028 1/20 0.55
MEN1 O00255 7/20 0.54
KMT2A Q03164 7/20 0.54
HTT P42858 6/20 0.54
NPC1 O15118 6/20 0.54
RAB9A P51151 6/20 0.54
POLB P06746 4/20 0.54
MAPT P10636 4/20 0.54
PKM P14618 4/20 0.54
NPSR1 Q6W5P4 4/20 0.54
BLM P54132 4/20 0.54
MAPK1 P28482 3/20 0.54
RECQL P46063 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
APAF1 O14727 2/20 0.54
ALDH1A1 P00352 2/20 0.54
THRB P10828 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
PLA2G1B P04054 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13232590 1.00 PRMT1 (1.00) PRMT1NSD2MEN1KMT2AHTT
SCHEMBL10036054 0.91 PRMT1 (0.83) PRMT1NSD2MEN1KMT2AHTT
SCHEMBL12311445 0.91 PRMT1 (0.83) PRMT1NSD2MEN1KMT2AHTT
SCHEMBL10036044 0.86 PRMT1 (0.76) PRMT1NSD2MEN1KMT2AHTT
SCHEMBL16867335 0.83 PRMT1 (0.73) PRMT1MEN1KMT2AHTTNPC1
SCHEMBL13222318 0.83 PRMT1 (0.73) PRMT1MEN1KMT2AHTTNPC1
SCHEMBL10035991 0.83 PRMT1 (0.73) PRMT1MEN1KMT2AHTTNPC1
Iodide SCHEMBL7908601 0.82 PRMT1 (0.73) PRMT1MEN1KMT2AHTTNPC1
SCHEMBL10036128 0.81 PRMT1 (0.69) PRMT1MEN1KMT2AHTTNPC1
SCHEMBL14509025 0.81 PRMT1 (0.69) PRMT1MEN1KMT2AHTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9465290-B2 Near-infrared absorbing film compositions GLOBALFOUNDRIES INC. (KY) 2016-10-11 US disclosed
US-20140210034-A1 NEAR-INFRARED ABSORBING FILM COMPOSITIONS INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2014-07-31 US disclosed
US-8772376-B2 Near-infrared absorbing film compositions INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2014-07-08 US disclosed
US-20120035187-A1 ANTI-NEURODEGENERATIVE DISEASE AGENT KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2012-02-09 US disclosed
WO-2011031396-A2 NEAR-INFRARED ABSORBING FILM COMPOSITIONS INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-03-17 WO disclosed
US-20110042771-A1 Near-Infrared Absorbing Film Compositions INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035187-A1 ANTI-NEURODEGENERATIVE DISEASE AGENT SNCA, PSEN1, CDR2 PRMT1 130/4885NSD2 2508/4885MEN1 2218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.